# SARS-COV-2 Screening in Dialysis Facilities

> **NCT05225298** · NA · COMPLETED · sponsor: **Stanford University** · enrollment: 2389 (actual)

## Conditions studied

- End-stage Renal Disease
- SARS-CoV-2 Acute Respiratory Disease
- Dialysis; Complications

## Interventions

- **BEHAVIORAL:** Offering SARS-CoV-2 test

## Key facts

- **NCT ID:** NCT05225298
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-06
- **Primary completion:** 2023-08-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 2389 (ACTUAL)
- **Last updated:** 2024-10-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05225298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05225298, "SARS-COV-2 Screening in Dialysis Facilities". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05225298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*